Table 4.
Variable | Direct effect (USDa) | Indirect effect (USDa) | Total effects (USDa) | ||||||
---|---|---|---|---|---|---|---|---|---|
→THC | →LOS→THC | →THC + (→LOS→THC) | |||||||
Coeff. | 95% CI | Coeff. | 95% CI | Coeff. | 95% CI | ||||
LOS (day) | 293 | 279 | 307 | 293 | 279 | 307 | |||
Gender (reference: male) | |||||||||
Female | −201 | −385 | −17 | 471 | 238 | 703 | 269 | −28 | 567 |
Hospitalization characteristics | |||||||||
Influenza as primary medical diagnosis | −526 | −690 | −361 | −1920 | −2160 | −1680 | −2446 | −2716 | −2176 |
Nature of hospitalization | |||||||||
Regular | Reference | Reference | Reference | ||||||
Emergency | 443 | 283 | 603 | −265 | −556 | 673 | 177 | −109 | 464 |
ICU | 4943 | 3966 | 5920 | 58 | −556 | 673 | 5002 | 3732 | 6272 |
Patient origin | |||||||||
From home | Reference | Reference | Reference | ||||||
Transfer | −332 | −929 | 265 | 815 | −179 | 1810 | 482 | −515 | 1481 |
Nursing home or welfare facilities | −662 | −875 | −448 | 124 | −221 | 470 | −537 | −922 | −152 |
Associated conditions | |||||||||
Congestive heart failure | −216 | −514 | 81 | 156 | −171 | 484 | −60 | −493 | 373 |
Atrial fibrillation | −198 | −589 | 192 | 48 | −368 | 465 | −150 | −687 | 387 |
Acute respiratory failure | −33 | −289 | 222 | −345 | −712 | 22 | −379 | −799 | 41 |
Acute renal failure | 1093 | −958 | 3145 | −715 | −1679 | 248 | 377 | −1967 | 2723 |
Pneumonia | −406 | −645 | −168 | −41 | −358 | 274 | −448 | −824 | −72 |
Asthma | −48 | −518 | 422 | 26 | −423 | 475 | −21 | −699 | 656 |
COPD | −316 | −601 | −30 | 287 | −159 | 733 | −28 | −542 | 484 |
Chronic renal failure | −1009 | −1516 | −502 | 58 | −595 | 713 | −950 | −1693 | −207 |
Diabetes mellitus | 182 | −82 | 448 | 73 | −207 | 355 | 256 | −132 | 645 |
Disease involving the immune mechanism | 5115 | −3837 | 14 067 | −874 | −3519 | 1770 | 4240 | −7000 | 15 481 |
Parkinson's disease | 11 | −386 | 409 | 1574 | 643 | 2505 | 1586 | 585 | 2586 |
Ischaemic heart disease | 271 | −132 | 675 | 336 | −53 | 726 | 608 | 82 | 1134 |
Malignant neoplasm (cancer) | 259 | −83 | 603 | 723 | 333 | 1112 | 982 | 453 | 1512 |
Procedures (patients with at least 1 procedure charged) | |||||||||
Surgery and interventions | |||||||||
Blood transfusion | 3354 | 2608 | 4099 | 2583 | 1936 | 3231 | 5938 | 4882 | 6993 |
Cardiac catheterization | 70 | −196 | 338 | 1516 | 1171 | 1862 | 1587 | 1167 | 2008 |
Dialysis | 2123 | 1232 | 3014 | 659 | −524 | 1842 | 2782 | 1288 | 4276 |
Mechanical ventilation | 2519 | 1590 | 3448 | −630 | −1316 | 55 | 1888 | 741 | 3035 |
Oxygen therapy | 241 | −53 | 536 | 150 | −204 | 505 | 392 | −86 | 870 |
Tube feeding | 1014 | 366 | 1662 | 2563 | 1956 | 3169 | 3578 | 2691 | 4464 |
Tests/imaging | |||||||||
Biochemical testing | 114 | −357 | 586 | −460 | −1313 | 392 | −345 | −1318 | 627 |
Bronchoscopy/pulmonary function test | 2222 | 1123 | 3322 | 1636 | 766 | 2506 | 3859 | 2407 | 5311 |
Chest X‐ray | 248 | −124 | 621 | 733 | 249 | 1218 | 982 | 374 | 1590 |
Colour Doppler ultrasound/echocardiography | 553 | 338 | 768 | 753 | 455 | 1051 | 1306 | 947 | 1665 |
Computerized tomography | −20 | −213 | 172 | 533 | 292 | 774 | 513 | 204 | 821 |
Immunology test | 37 | −324 | 399 | 1166 | 711 | 1620 | 1203 | 619 | 1788 |
Oxygen saturation test | −51 | −334 | 231 | 258 | −83 | 600 | 207 | −246 | 660 |
Sputum test | −212 | −431 | 6 | 474 | 241 | 708 | 262 | −58 | 582 |
Statistical significance at P‐value < 0.05 in bold. Coeff., unstandardized coefficient; USD, US$; LOS, length of stay; THC, total healthcare cost; COPD, chronic obstructive pulmonary disease.
Exchange rate: 1 USD = 109.33 Japanese yen.